Archimed acquires and merges Symbio and ProInnovera

Global private equity healthcare specialist Archimed acquired and simultaneously merged US-based Symbio and Germany-based ProInnovera in an all-equity deal.

“Global Private Equity healthcare specialist ARCHIMED has acquired and simultaneously merged US-based Symbio, and Germany-based Proinnovera in all-equity deal.”achelous.com

• 1 source
• achelous.comAchelous Partners Advises Symbio and ProInnovera on their respective sales to Archimed - Achelous Partnersdev_teamNov 17, 2023

Summarized from public sources; check the original articles before acting on it.